Correlation Between Ardelyx and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Ardelyx and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ardelyx and Inozyme Pharma, you can compare the effects of market volatilities on Ardelyx and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Inozyme Pharma.
Diversification Opportunities for Ardelyx and Inozyme Pharma
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Ardelyx and Inozyme is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Ardelyx i.e., Ardelyx and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Ardelyx and Inozyme Pharma
Given the investment horizon of 90 days Ardelyx is expected to generate 1.02 times more return on investment than Inozyme Pharma. However, Ardelyx is 1.02 times more volatile than Inozyme Pharma. It trades about 0.05 of its potential returns per unit of risk. Inozyme Pharma is currently generating about 0.0 per unit of risk. If you would invest 314.00 in Ardelyx on November 2, 2024 and sell it today you would earn a total of 233.00 from holding Ardelyx or generate 74.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ardelyx vs. Inozyme Pharma
Performance |
| Timeline |
| Ardelyx |
| Inozyme Pharma |
Ardelyx and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ardelyx and Inozyme Pharma
The main advantage of trading using opposite Ardelyx and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Ardelyx vs. BioLineRx | Ardelyx vs. Lexicon Pharmaceuticals | Ardelyx vs. Seres Therapeutics | Ardelyx vs. Immunitybio |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |